We found that increased expression of SMC2, SMC3, and SMC4 might play a significant role in HCC, and could be useful as molecular markers to identify high-risk patients, Our results also provide insights for further research of SMC family members as potential tumor therapeutic target in HCC. This evidence concerns the gene SMC3 and hepatocellular carcinoma.